HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Akihiko Asahina Selected Research
Akihiko Asahina Research Topics
Disease
47
Psoriasis (Pustulosis Palmaris et Plantaris)
02/2024 - 11/2002
17
Psoriatic Arthritis
02/2024 - 01/2003
10
Atopic Dermatitis (Atopic Eczema)
10/2023 - 11/2002
5
Infections
02/2023 - 02/2002
5
Arthritis (Polyarthritis)
02/2023 - 08/2010
5
Melanoma (Melanoma, Malignant)
01/2023 - 01/2019
5
Inflammation (Inflammations)
03/2022 - 08/2010
4
Neoplasms (Cancer)
08/2022 - 10/2002
3
Necrosis
02/2024 - 06/2021
3
Bullous Pemphigoid (Pemphigoid)
11/2023 - 02/2015
3
Hypersensitivity (Allergy)
10/2023 - 06/2007
3
Interstitial Lung Diseases (Interstitial Lung Disease)
06/2021 - 06/2016
3
Pemphigus (Pemphigus Vulgaris)
05/2020 - 01/2007
3
Rheumatoid Arthritis
12/2017 - 07/2010
3
Virus Diseases (Viral Diseases)
10/2006 - 01/2003
2
Neurofibromatosis 1 (Neurofibromatosis Type I)
04/2024 - 11/2020
2
Neurofibroma
04/2024 - 11/2020
2
Rosacea (Acne Rosacea)
10/2023 - 11/2022
2
Pruritus (Itching)
10/2023 - 09/2020
2
Prostatic Neoplasms (Prostate Cancer)
09/2023 - 04/2022
2
Pain (Aches)
01/2023 - 11/2016
2
Squamous Cell Carcinoma (Epidermoid Carcinoma)
11/2022 - 09/2020
2
Erythema
05/2021 - 07/2017
2
Drug-Related Side Effects and Adverse Reactions
03/2020 - 09/2013
2
Skin Diseases (Skin Disease)
07/2016 - 01/2012
2
Dermatitis
10/2015 - 08/2010
2
Hyperpigmentation
12/2008 - 09/2007
2
Dermatomyositis (Dermatopolymyositis)
10/2006 - 01/2006
1
Flushing
10/2023
1
Myocardial Infarction
09/2023
1
Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
04/2023
1
Lymphoma (Lymphomas)
04/2023
Drug/Important Bio-Agent (IBA)
14
Adalimumab (Humira)
FDA Link
02/2023 - 04/2010
12
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
02/2023 - 10/2002
11
Ustekinumab (CNTO 1275)
FDA Link
03/2023 - 09/2013
6
bimekizumab
IBA
02/2024 - 01/2023
6
Interleukins
IBA
09/2023 - 01/2019
6
Infliximab (Remicade)
FDA Link
02/2023 - 09/2013
5
Interleukin-12 (IL 12)
IBA
05/2023 - 11/2002
5
Cytokines
IBA
05/2023 - 10/2002
5
Iodine
IBA
03/2022 - 07/2016
5
Proteins (Proteins, Gene)
FDA Link
10/2019 - 02/2002
4
Interferons
IBA
05/2023 - 10/2002
4
Interleukin-17 (Interleukin 17)
IBA
01/2023 - 08/2010
4
C-Reactive Protein
IBA
06/2022 - 07/2016
4
Biomarkers (Surrogate Marker)
IBA
05/2021 - 10/2017
4
Monoclonal Antibodies
IBA
09/2018 - 04/2010
3
Nivolumab
IBA
11/2023 - 03/2018
3
Immunoglobulin A (IgA)
IBA
10/2023 - 02/2015
3
secukinumab
IBA
09/2023 - 03/2018
3
Antibodies
IBA
02/2023 - 02/2015
3
Chemokine CCL17
IBA
07/2021 - 10/2002
3
Ligands
IBA
09/2020 - 10/2002
3
Immunoglobulin E (IgE)
IBA
09/2020 - 02/2015
3
Immunoglobulin G (IgG)
IBA
02/2015 - 01/2003
2
Antirheumatic Agents (DMARD)
IBA
11/2023 - 01/2023
2
apalutamide
IBA
09/2023 - 04/2022
2
Interleukin-23 (Interleukin 23)
IBA
09/2023 - 05/2023
2
Interleukin-22 (IL-22)
IBA
05/2023 - 09/2020
2
Janus Kinase Inhibitors
IBA
05/2023 - 08/2016
2
Interleukin-1 (Interleukin 1)
IBA
04/2023 - 08/2010
2
Rituximab (Mabthera)
FDA Link
04/2023 - 01/2019
2
L-Lactate Dehydrogenase (Lactate Dehydrogenase)
IBA
07/2021 - 09/2020
2
dupilumab
IBA
06/2021 - 09/2020
2
Certolizumab Pegol
FDA Link
06/2021 - 09/2018
2
Prostaglandins A
IBA
06/2021 - 08/2016
2
Imatinib Mesylate (Gleevec)
FDA Link
11/2020 - 10/2006
2
Interleukin-2 Receptors (IL 2 Receptor)
IBA
09/2020 - 03/2003
2
Antiviral Agents (Antivirals)
IBA
01/2020 - 07/2005
2
Immunoglobulins (Immunoglobulin)
IBA
01/2019 - 01/2018
2
Enzymes
IBA
01/2019 - 01/2019
2
Immunosorbents
IBA
01/2019 - 01/2019
2
Tyrosine (L-Tyrosine)
FDA Link
01/2019 - 01/2018
2
Etanercept (Enbrel)
FDA Link
12/2017 - 07/2010
2
Steroids
IBA
07/2017 - 09/2008
2
Adrenal Cortex Hormones (Corticosteroids)
IBA
07/2016 - 09/2008
2
Potassium Iodide (Pima)
FDA Link
10/2015 - 01/2006
2
Intravenous Immunoglobulins (IVIG)
FDA Link
01/2006 - 01/2003
1
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
04/2024
1
Thymidine Monophosphate (TMP)
IBA
10/2023
1
Sulfur
IBA
10/2023
1
Metronidazole (Metric)
FDA Link
Generic
10/2023
1
Androgen Antagonists (Antiandrogens)
IBA
09/2023
1
guselkumab
IBA
09/2023
1
Interleukin-23 Subunit p19
IBA
09/2023
1
mirikizumab
IBA
09/2023
1
risankizumab
IBA
09/2023
1
upadacitinib
IBA
05/2023
1
TYK2 Kinase (Tyrosine Kinase 2)
IBA
05/2023
1
Interleukin-7 (Interleukin 7)
IBA
05/2023
1
deucravacitinib
IBA
05/2023
1
Janus Kinases
IBA
05/2023
1
interleukin-21 (interleukin 21)
IBA
05/2023
1
Immunoglobulin M (IgM)
IBA
04/2023
1
canakinumab
FDA Link
04/2023
Therapy/Procedure
16
Therapeutics
10/2023 - 01/2003
2
Aftercare (After-Treatment)
11/2022 - 09/2007
2
Solid-State Lasers
05/2021 - 12/2008
2
Lasers (Laser)
12/2008 - 09/2007
1
Plasma Exchange
11/2023